Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hepatitis C virus p7 ion channel is a small, 63-amino acid hydrophobic protein that functions as a viroporin, essential for the production of infectious viral particles (UniProt: P26664). It oligomerizes into hexameric or heptameric complexes that form cation-selective channels within host cell membranes, particularly the endoplasmic reticulum and Golgi apparatus (PubMed: 23396147). While p7 is not required for viral genome replication, it plays a pivotal role in the late stages of the viral life cycle, including the assembly and maturation of virions (PubMed: 23408621). By acting as a proton channel, it helps to neutralize acidic compartments, thereby protecting the pH-sensitive viral glycoproteins from premature conformational changes or degradation (PubMed: 20862355). This protein is considered a viable therapeutic target, and several classes of inhibitors, such as amantadine and BIT225, have been identified to block its ion channel activity (PubMed: 20444935). However, the high genetic variability among HCV genotypes presents a significant challenge for the development of universal p7 inhibitors (PubMed: 24218191). Additionally, the potential for rapid emergence of resistance mutations necessitates the use of p7 inhibitors in combination with other direct-acting antivirals (PubMed: 24218191).
Inhibition of the p7 viroporin ion channel activity, which prevents the equilibration of pH in intracellular compartments and disrupts the assembly and release of infectious HCV progeny (PubMed: 20444935).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus p7 ion channel (p7) (p7).